Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 474

1.

Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis Fungoides.

Foss F, Duvic M, Lerner A, Waksman J, Whittaker S.

Clin Lymphoma Myeloma Leuk. 2016 Aug 10. pii: S2152-2650(16)30383-4. doi: 10.1016/j.clml.2016.08.009. [Epub ahead of print]

PMID:
27637428
2.

Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy.

Litvinov IV, Shtreis A, Kobayashi K, Glassman S, Tsang M, Woetmann A, Sasseville D, Ødum N, Duvic M.

Oncoimmunology. 2016 Jun 6;5(7):e1175799. doi: 10.1080/2162402X.2016.1175799. eCollection 2016 Jul. Review.

PMID:
27622024
3.

Discovery and clinical introduction of first-in-class imipridone ONC201.

Allen JE, Kline CL, Prabhu VV, Wagner J, Ishizawa J, Madhukar N, Lev A, Baumeister M, Zhou L, Lulla A, Stogniew M, Schalop L, Benes C, Kaufman HL, Pottorf RS, Nallaganchu BR, Olson GL, Al-Mulla F, Duvic M, Wu GS, Dicker DT, Talekar MK, Lim B, Elemento O, Oster W, Bertino J, Flaherty K, Wang ML, Borthakur G, Andreeff M, Stein M, El-Deiry WS.

Oncotarget. 2016 Sep 1. doi: 10.18632/oncotarget.11814. [Epub ahead of print]

4.

Granulomatous Mycosis Fungoides in an Adolescent-A Rare Encounter and Review of the Literature.

Wieser I, Wohlmuth C, Duvic M.

Pediatr Dermatol. 2016 Sep;33(5):e296-8. doi: 10.1111/pde.12959.

PMID:
27595880
5.

Essential role of DNA methyltransferase 1-mediated transcription of insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors.

Min HY, Lee SC, Woo JK, Jung HJ, Park KH, Jeong HM, Hyun SY, Cho J, Lee W, Park JE, Kwon SJ, Lee HJ, Ni X, Shin YK, Johnson FM, Duvic M, Lee HY.

Clin Cancer Res. 2016 Aug 31. pii: clincanres.0534.2016. [Epub ahead of print]

PMID:
27582487
6.

Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma.

Alberti-Violetti S, Torres-Cabala CA, Talpur R, Corti L, Fanoni D, Venegoni L, Berti E, Duvic M.

J Cutan Pathol. 2016 Aug 23. doi: 10.1111/cup.12806. [Epub ahead of print]

PMID:
27550169
7.

Primary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings.

Ramani NS, Curry JL, Merrill ED, Aung PP, Prieto V, Tetzlaff MT, Duvic M, Miranda R, Torres-Cabala C.

Am J Dermatopathol. 2016 Oct;38(10):e147-9. doi: 10.1097/DAD.0000000000000608.

PMID:
27533072
8.

Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding.

Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, Curry JL, Miranda RN, Duvic M, Prieto VG, Aung PP.

J Cutan Pathol. 2016 Aug 17. doi: 10.1111/cup.12797. [Epub ahead of print]

PMID:
27531242
9.

Cutaneous T-cell lymphoma in a patient with celiac disease.

Wang CM, Nadeem S, Jahan-Tigh RR, Duvic M.

Cutis. 2016 Jul;98(1):E1-2. No abstract available.

PMID:
27529713
10.

Primary cutaneous CD30(+) lymphoproliferative disorders.

Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M.

J Dtsch Dermatol Ges. 2016 Aug;14(8):767-82. doi: 10.1111/ddg.13117.

PMID:
27509411
11.

Primär kutane CD30(+) lymphoproliferative Erkrankungen.

Wieser I, Tetzlaff MT, Cabala CA, Duvic M.

J Dtsch Dermatol Ges. 2016 Aug;14(8):767-84. doi: 10.1111/ddg.13117_g.

PMID:
27509410
12.

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.

Jabbari A, Cerise JE, Chen JC, Mackay-Wiggan J, Duvic M, Price V, Hordinsky M, Norris D, Clynes R, Christiano AM.

EBioMedicine. 2016 May;7:240-7. doi: 10.1016/j.ebiom.2016.03.036. Epub 2016 Mar 31.

13.

ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.

Napoli M, Venkatanarayan A, Raulji P, Meyers BA, Norton W, Mangala LS, Sood AK, Rodriguez-Aguayo C, Lopez-Berestein G, Vin H, Duvic M, Tetzlaff MB, Curry JL, Rook AH, Abbas HA, Coarfa C, Gunaratne PH, Tsai KY, Flores ER.

Cancer Cell. 2016 Jun 13;29(6):874-88. doi: 10.1016/j.ccell.2016.04.016.

PMID:
27300436
14.

Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential.

Duvic M, Evans M, Wang C.

Ther Adv Hematol. 2016 Jun;7(3):171-4. doi: 10.1177/2040620716636541. Epub 2016 Mar 17. Review.

15.

Scleromyxedema: long-term follow-up after high-dose melphalan with autologous stem cell transplantation.

Chockalingam R, Duvic M.

Int J Dermatol. 2016 Oct;55(10):e539-43. doi: 10.1111/ijd.13315. Epub 2016 May 21.

PMID:
27207484
16.

Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review.

Wieser I, Wohlmuth C, Nunez CA, Duvic M.

Am J Clin Dermatol. 2016 Aug;17(4):319-27. doi: 10.1007/s40257-016-0192-6. Review.

PMID:
27138554
17.

An unusual case of cytotoxic peripheral T-cell lymphoma.

Wang C, Reusser N, Shelton M, Reed J, Doan H, Torres-Cabala CA, Dabaja B, Duvic M.

JAAD Case Rep. 2015 Jul 28;1(5):257-60. doi: 10.1016/j.jdcr.2015.04.016. eCollection 2015 Sep. No abstract available.

18.

Reed syndrome presenting with leiomyosarcoma.

Wang C, Tetzlaff M, Hick R, Duvic M.

JAAD Case Rep. 2015 May 25;1(3):150-2. doi: 10.1016/j.jdcr.2015.02.004. eCollection 2015 May. No abstract available.

19.

BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.

Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Milton DR, Tsai KY, Prieto VG, Torres-Cabala CA, Curry JL.

Hum Pathol. 2016 Apr;50:79-89. doi: 10.1016/j.humpath.2015.12.003. Epub 2015 Dec 18.

PMID:
26997441
20.

The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studies.

Duvic M, Dimopoulos M.

Cancer Treat Rev. 2016 Feb;43:58-66. doi: 10.1016/j.ctrv.2015.04.003. Epub 2015 Apr 9. Review.

PMID:
26827693
Items per page

Supplemental Content

Write to the Help Desk